BACKGROUND: Mutations in myofilament proteins, most commonly MYBPC3-encoded myosin-binding protein C and MYH7-encoded beta-myosin heavy chain, can cause hypertrophic cardiomyopathy (HCM). Despite significant advances in structure-function relationships pertaining to the cardiac sarcomere, there is limited knowledge of how a mutation leads to clinical HCM. We, therefore, set out to study expression and localization of myofilament proteins in left ventricular tissue of patients with HCM. METHODS AND RESULTS: Frozen surgical myectomy specimens from 47 patients with HCM were examined and genotyped for mutations involving 8 myofilament-encoding genes. Myofilament protein levels were quantified by Western blotting with localization graded from immunohistochemical staining of tissue sections. Overall, 25 of 47 (53%) patients had myofilament-HCM, including 12 with MYBPC3-HCM and 9 with MYH7-HCM. As compared with healthy heart tissue, levels of myofilament proteins were increased in patients manifesting a mutation in either gene. Patients with a frameshift mutation predicted to truncate MYBPC3 exhibited marked disturbances in protein localization as compared with missense mutations in either MYBPC3 or MYH7. CONCLUSIONS: In this first expression study in human HCM tissue, increased myofilament protein levels in patients with either MYBPC3- or MYH7-mediated HCM suggest a poison peptide mechanism. Specifically, the mechanism of dysfunction may vary according to the genetic subgroup suggested by a distinctly abnormal distribution of myofilament proteins in patients manifesting a truncation mutation in MYBPC3.
BACKGROUND: Mutations in myofilament proteins, most commonly MYBPC3-encoded myosin-binding protein C and MYH7-encoded beta-myosin heavy chain, can cause hypertrophic cardiomyopathy (HCM). Despite significant advances in structure-function relationships pertaining to the cardiac sarcomere, there is limited knowledge of how a mutation leads to clinical HCM. We, therefore, set out to study expression and localization of myofilament proteins in left ventricular tissue of patients with HCM. METHODS AND RESULTS: Frozen surgical myectomy specimens from 47 patients with HCM were examined and genotyped for mutations involving 8 myofilament-encoding genes. Myofilament protein levels were quantified by Western blotting with localization graded from immunohistochemical staining of tissue sections. Overall, 25 of 47 (53%) patients had myofilament-HCM, including 12 with MYBPC3-HCM and 9 with MYH7-HCM. As compared with healthy heart tissue, levels of myofilament proteins were increased in patients manifesting a mutation in either gene. Patients with a frameshift mutation predicted to truncate MYBPC3 exhibited marked disturbances in protein localization as compared with missense mutations in either MYBPC3 or MYH7. CONCLUSIONS: In this first expression study in human HCM tissue, increased myofilament protein levels in patients with either MYBPC3- or MYH7-mediated HCM suggest a poison peptide mechanism. Specifically, the mechanism of dysfunction may vary according to the genetic subgroup suggested by a distinctly abnormal distribution of myofilament proteins in patients manifesting a truncation mutation in MYBPC3.
Authors: J Flavigny; M Souchet; P Sébillon; I Berrebi-Bertrand; B Hainque; A Mallet; A Bril; K Schwartz; L Carrier Journal: J Mol Biol Date: 1999-11-26 Impact factor: 5.469
Authors: Samantha P Harris; Christopher R Bartley; Timothy A Hacker; Kerry S McDonald; Pamela S Douglas; Marion L Greaser; Patricia A Powers; Richard L Moss Journal: Circ Res Date: 2002-03-22 Impact factor: 17.367
Authors: B K McConnell; K A Jones; D Fatkin; L H Arroyo; R T Lee; O Aristizabal; D H Turnbull; D Georgakopoulos; D Kass; M Bond; H Niimura; F J Schoen; D Conner; D A Fischman; C E Seidman; J G Seidman; D H Fischman Journal: J Clin Invest Date: 1999-11 Impact factor: 14.808
Authors: J A Moolman; S Reith; K Uhl; S Bailey; M Gautel; B Jeschke; C Fischer; J Ochs; W J McKenna; H Klues; H P Vosberg Journal: Circulation Date: 2000-03-28 Impact factor: 29.690
Authors: A J Marian; Y Wu; D S Lim; M McCluggage; K Youker; Q T Yu; R Brugada; F DeMayo; M Quinones; R Roberts Journal: J Clin Invest Date: 1999-12 Impact factor: 14.808
Authors: Dan F Smelter; Willem J de Lange; Wenxuan Cai; Ying Ge; J Carter Ralphe Journal: Am J Physiol Heart Circ Physiol Date: 2018-02-16 Impact factor: 4.733
Authors: Candida L Desjardins; Yong Chen; Arthur T Coulton; Brian D Hoit; Xin Yu; Julian E Stelzer Journal: Circ Cardiovasc Imaging Date: 2011-12-07 Impact factor: 7.792
Authors: Andrew P Landstrom; Cherisse A Kellen; Sayali S Dixit; Ralph J van Oort; Alejandro Garbino; Noah Weisleder; Jianjie Ma; Xander H T Wehrens; Michael J Ackerman Journal: Circ Heart Fail Date: 2011-01-07 Impact factor: 8.790
Authors: Sabine Huke; Raghav Venkataraman; Michela Faggioni; Sirish Bennuri; Hyun S Hwang; Franz Baudenbacher; Björn C Knollmann Journal: Circ Res Date: 2013-03-26 Impact factor: 17.367
Authors: Anita C Hoskins; Adam Jacques; Sonya C Bardswell; William J McKenna; Victor Tsang; Cristobal G dos Remedios; Elisabeth Ehler; Kim Adams; Shapour Jalilzadeh; Metin Avkiran; Hugh Watkins; Charles Redwood; Steven B Marston; Jonathan C Kentish Journal: J Mol Cell Cardiol Date: 2010-07-06 Impact factor: 5.000
Authors: Adam S Helms; Frank M Davis; David Coleman; Sarah N Bartolone; Amelia A Glazier; Francis Pagani; Jaime M Yob; Sakthivel Sadayappan; Ellen Pedersen; Robert Lyons; Margaret V Westfall; Richard Jones; Mark W Russell; Sharlene M Day Journal: Circ Cardiovasc Genet Date: 2014-07-16
Authors: Y Cheng; X Wan; T A McElfresh; X Chen; K S Gresham; D S Rosenbaum; M P Chandler; J E Stelzer Journal: Am J Physiol Heart Circ Physiol Date: 2013-05-10 Impact factor: 4.733